Related Experiment Video
Updated: May 21, 2026

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
FOXP3 expression in tumor cells and implications for cancer progression
Tiziana Triulzi1, Elda Tagliabue, Andrea Balsari
1Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS-Istituto Nazionale dei Tumori, Milan, Italy.
Abstract:
FOXP3 is a member of the forkhead/winged-helix family of transcriptional regulators. Defects in the FOXP3 gene cause an X-linked autoimmune/immunodeficiency syndrome in humans and the Scurfy phenotype in mice. FOXP3 acts mainly in regulating the development and function of CD4+CD25+ regulatory T cells. Although initially thought to be specific for these cells, FOXP3 expression has recently been described in non-hematopoietic cells, including epithelial cells of multiple lineages and of different tissue origins. Moreover, FOXP3 expression has been detected in tumor cells of both epithelial and non-epithelial tissues. The role of FOXP3 expression by tumor cells remains controversial, with in vitro studies pointing to an onco-suppressive action, whereas studies conducted on human samples associate FOXP3 expression by tumor cells with metastatic spread. Here, we review evidence for the multi-faceted role of FOXP3 in cancer cells.
Insights
Forkhead box protein 3 (FOXP3) regulates T cells but is also found in cancer cells. Its role in tumors is debated, with conflicting evidence on whether it suppresses or promotes cancer progression.
Area of Science:
- Molecular Biology
- Immunology
- Oncology
Background:
- Forkhead box protein 3 (FOXP3) is a transcriptional regulator crucial for regulatory T cell development and function.
- FOXP3 expression is not limited to immune cells, having been identified in various non-hematopoietic and tumor cells.
Purpose of the Study:
- To review the diverse roles of FOXP3 in cancer cells.
- To explore the controversial functions of FOXP3 in tumor progression and metastasis.
Main Methods:
- Literature review of existing studies on FOXP3 expression in cancer.
- Analysis of in vitro and human sample data regarding FOXP3's impact on tumor cells.
Main Results:
- FOXP3 expression in tumor cells has been linked to metastatic spread in human studies.
- In vitro research suggests FOXP3 may possess tumor-suppressive functions.
Conclusions:
- The role of FOXP3 in cancer is complex and context-dependent.
- Further research is needed to elucidate FOXP3's precise function in tumorigenesis and metastasis.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Tumor Microenvironment
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
